Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | 7819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| H-Ser-His-OH | C9H14N4O4 | 67726-09-4 | Details |
| HCV-IN-30 | C36H44N6O4 | 1007882-23-6 | Details |
| H3B-6545 | C30H29F4N5O2 | 2052130-80-8 | Details |
| Haloperidol (D4')；Haloperidol D4' | C21H19ClD4FNO2 | 136765-35-0 | Details |
| Hck-IN-1 | C16H11ClN6O3S | 1473404-51-1 | Details |
| H4R antagonist 1 | C11H11BrN8 | 1429375-54-1 | Details |
| HCV-IN-3 | C13H11F2NO | 1401839-25-5 | Details |
| Rifaximin | C43H51N3O11 | 80621-81-4 | Details |
| Trimethoprim | C14H18N4O3 | 738-70-5 | Details |
| GW311616 hydrochloride；GW311616A | C19H32ClN3O4S | 197890-44-1 | Details |
| Haloperidol D4 | C21H19ClD4FNO2 | 1189986-59-1 | Details |
| HA155；CS-963 | C24H19BFNO5S | 1312201-00-5 | Details |
| H100 | C18H16N2O6S | 643727-55-3 | Details |
| HS79 | C19H22N4S | 2138838-56-7 | Details |
| GW311616 | C19H31N3O4S | 198062-54-3 | Details |
| HCV-IN-29 | C26H32Cl4N6 | 1009119-83-8 | Details |
| H3B-6545 Hydrochloride | C30H30ClF4N5O2 | 2052132-51-9 | Details |
| H3B-120 | C19H24N4O2S | 2194903-42-7 | Details |
| HIV-1 integrase inhibitor 4 | C24H20F2N4O5S | 1638504-66-1 | Details |
| hDHODH-IN-2 | C19H16N2O2 | 183946-00-1 | Details |
| Heptamidine dimethanesulfonate | C22H32N4O5S | 161374-55-6 | Details |
| HIF-2α-IN-2 | C17H13F2NO4S | 1672666-82-8 | Details |
| HDAC-IN-4 | C20H21N3O2 | 1252003-13-6 | Details |
| Palonosetron hydrochloride | C19H25ClN2O | 135729-62-3 | Details |
| hDHODH-IN-1 | C17H14N2O2 | 1173715-42-8 | Details |
| Helioxanthin derivative 5-4-2；Helioxanthin 5-4-2 | C20H13NO5 | 203935-39-1 | Details |
| HS80 | C19H22N4S | 2138838-57-8 | Details |
| Cathepsin Inhibitor 2 | C19H21F6N3O | 1017931-53-1 | Details |
| Encequidar | C38H36N6O7 | 849675-66-7 | Details |
| Histone Acetyltransferase Inhibitor II | C20H16Br2O3 | 932749-62-7 | Details |
| HIF-2α-IN-3 | C12H6ClN5O5 | 313964-19-1 | Details |
| Mebendazole | C16H13N3O3 | 31431-39-7 | Details |
| HCV-IN-7 | C40H48N8O6S | 1449756-86-8 | Details |
| Hydroxyamine hydrochloride | NH2OH·HCl | 5470-11-1 | Details |
| Hydroxyzine D8 | C21H19ClD8N2O2 | 1189480-47-4 | Details |
| Ibiglustat (L-Malic acid) | C24H30FN3O7S | 1629063-78-0 | Details |
| I2906 | C25H37N3O4 | 331963-29-2 | Details |
| Hydroxybupropion | C13H18ClNO2 | 92264-81-8 | Details |
| IACS-9571；ASIS-P040 | C32H42N4O8S | 1800477-30-8 | Details |
| Hydroxycitric acid tripotassium hydrate；Potassium citrate monohydrate | C6H11KO8 | 6100-05-6 | Details |
| (-)-Hydroxycitric acid；Garcinia acid | C6H8O8 | 27750-10-3 | Details |
| Hydroxyzine D4 | C21H27ClN2O2 | 2070014-84-3 | Details |
| Leflunomide | C12H9F3N2O2 | 75706-12-6 | Details |
| HDACs/mTOR Inhibitor 1 | C28H38N8O5 | 2271413-06-8 | Details |
| hDDAH-1-IN-2 | C8H20N4O2 | 2408834-77-3 | Details |
| Hexyl gallate | C13H18O5 | 1087-26-9 | Details |
| Helvolic acid；Fumigacin | C33H44O8 | 29400-42-8 | Details |
| HET0016 | C12H18N2O | 339068-25-6 | Details |
| Helioxanthin 8-1；Helioxanthin analogue 8-1 | C20H12N2O6 | 840529-13-7 | Details |
| HCV-IN-7 hydrochloride | C40H49ClN8O6S | 1449756-87-9 | Details |
| FASN-IN-3 | C24H24N4O | 2097262-60-5 | Details |
| Encequidar mesylate | C39H40N6O10S | 849675-87-2 | Details |
| HIV-1 integrase inhibitor 3 | C21H22F2N4O4 | 1638504-56-9 | Details |
| HKI-357 | C31H29ClFN5O3 | 848133-17-5 | Details |
| HLY78 | C17H17NO2 | 854847-61-3 | Details |
| HIV-1 integrase inhibitor 7 | C30H26O16 | 204268-03-1 | Details |
| HWL-088 | C22H19FO4 | 2378617-96-8 | Details |
| Moxidectin | C37 H53 N O8 | 113507-06-5 | Details |
| Heptasaccharide Glc4Xyl3 | C39H66O33 | 121591-98-8 | Details |
| HSV-TK substrate | C11H15N5O4 | 111687-37-7 | Details |
| Heme Oxygenase-1-IN-1 hydrochloride；HO-1-IN-1 hydrochloride | C13H16BrClN2 | 1092851-70-1 | Details |
| Heme Oxygenase-1-IN-1；HO-1-IN-1 | C13H15BrN2 | 1093058-52-6 | Details |
| Phenoxybenzamine hydrochloride | C18H22ClNO.ClH | 63-92-3 | Details |
| HG-12-6 | C29H27F3N6O2S | 2222354-57-4 | Details |
| Hydroxy ziprasidone | C21H21ClN4O2S | 884305-08-2 | Details |
| HIV-1 integrase inhibitor | C11H9N3O4 | 544467-07-4 | Details |
| IAXO-102 | C35H71NO5 | 1115270-63-7 | Details |
| Epanolol；Visacor;ICI141292 | C20H23N3O4 | 86880-51-5 | Details |
| ICI 153110 | C11H11N3O | 87164-90-7 | Details |
| IDH1 Inhibitor 2 | C26H22N4O | 2244895-42-7 | Details |
| Ibuprofen-d3；(±)-Ibuprofen D3;Ibuprofen D3 | C13H15D3O2 | 121662-14-4 | Details |
| Fusidic acid | C31H48O6 | 6990-06-3 | Details |
| Ibrutinib-d5；PCI-32765 D5;Ibrutinib D5 | C25H24N6O2 | 1553977-17-5 | Details |
| Prothionamide | C9H12N2S | 14222-60-7 | Details |
| ICI 118,551 hydrochloride | C17H28ClNO2 | 72795-01-8 | Details |
| Ibrutinib dimer | C50H48N12O4 | 2031255-23-7 | Details |
| Ibrutinib-MPEA | C32H39N9O2 | 1710768-30-1 | Details |
| (-)-Ibuprofenamide；(R)-Ibuprofenamide | C13H17NO3 | 121839-78-9 | Details |
| IBR2 | C24H20N2O2S | 313526-24-8 | Details |
| IDH1 Inhibitor 3 | C31H25F4N5O3 | 2171081-24-4 | Details |
| IACS-8803 | C20H23FN10O9P2S2 | 2095690-70-1 | Details |
| Heptamidine；SBi4211 | C21H28N4O2 | 94345-47-8 | Details |
| HSL-IN-3 | C14H19BO4 | 346656-34-6 | Details |
| HSL-IN-1 | C19H13BClF3N2O4 | 2095156-13-9 | Details |
| BAY 59-9435；HSL-IN-2 | C14H22N2O3 | 654059-21-9 | Details |
| HDAC-IN-5 | C26H24F3N5O2S | 1314890-51-1 | Details |
| I-OMe-Tyrphostin AG 538 | C17H12INO5 | 1094048-77-7 | Details |
| IACS-8779 | C21H25N9O10P2S2 | 2243079-26-5 | Details |
| Hydroxy desmethyl Bosentan；Ro 64-1056 | C26H27N5O7S | 253688-62-9 | Details |
| hDDAH-1-IN-1 | C8H20N4O | 1229238-69-0 | Details |
| HPN-01 | C19H16ClN3O3S | 928655-63-4 | Details |
| HIV-1 inhibitor-3 | C9H10F2N2O5 | 1612841-22-1 | Details |
| hDDAH-1-IN-1 TFA | C10H21F3N4O3 | 1229238-70-3 | Details |
| HL271 | C13H17ClF3N5O | 1422365-52-3 | Details |
| DPP-IV-IN-2 | C18H26N4O5 | 136259-18-2 | Details |
| HAT-IN-1 | C23H18BrF4N3O4 | 1889281-94-0 | Details |
| Idelalisib D5；CAL-101 D5;GS-1101 D5 | C22H18FN7O | 1830330-31-8 | Details |
| HSR6071 | C10H12N8O | 111374-21-1 | Details |
| hGPR91 antagonist 1 | C31H23F4N3O | 1314796-00-3 | Details |
| Haemanthamine | C17H19NO4 | 466-75-1 | Details |
| Product Total： Product Page： | ||||
| 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 | ||||